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Toxicological evaluation of the whole fruit of Lagenaria breviflora was carried out using the serum 
biochemical changes accompanying prolonged administration of the ethanolic extract of the fruit in 
Wistar rats. Twenty five rats were randomly but equally divided into five groups. Rats in groups B, C, D 
and E were administered with ethanolic extract at 1000, 2000, 4000 and 8000 mg/kg body weight, 
respectively, while rats in group A received 0.9% physiological saline as the control animals. The lower 
doses of the extract (1000 and 2000 mg/kg body weight) lowered the serum levels of total cholesterol 
(TC), triglycerides (TG) and low density lipoprotein-cholesterol (LDL-C), while high-density lipoprotein-
cholesterol (HDL-C) was elevated. Higher doses of 4000 and 8000 mg/kg body weight of the extract 
increased the serum levels of TG and LDL-C and, lowers HDL-C level in the serum. There was dose-
dependent elevation of serum glucose level in rats administered with the extract. The serum value of 
glucose in rats administered with the extract of 8000 mg/kg body weight increased two and half-fold 
over the control value. The mean serum total protein value increased for all the treatment groups when 
compared with that of the rats in the control group. The serum creatinine (CRT) level increased dose-
dependently and blood urea nitrogen (BUN) was elevated two-fold in most of the test groups. This was 
corroborated with histopathological findings revealing marked renal tubular degeneration. The serum 
level of ALP increased significantly (P < 0.05) in test rats administered the highest dose of the extract. It 
was concluded that therapeutic application of the extract of L. breviflora is quite safe at lower doses but 
it is nephrotoxic and can precipitate hyperglycaemia and dyslipidaemia at higher doses. 
 





The fruit of Lagenaria breviflora Roberty is widely used in 
folklore medicine in West Africa as herbal remedy for the 
treatment of measles, digestive disorders, and as wound 
antiseptics (e.g. umbilical incision wound) in man, while 
the livestock farmers use it for treatment of Newcastle 
disease and coccidiosis in various animal species, espe-
cially poultry (Sonaiya, 1999). Laboratory investigations 
have shown evidences in support of its anti-implantation 
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activity (Ajayi et al., 2002) and antibacterial activity 
(Tomori et al., 2007). In addition to its medicinal application, 
so much have been reported on the taxonomy (Morimoto 
et al., 2005) and chemical constituents (Elujoba and El-
Alfy, 1986; Elujoba et al., 1991; Esuoso and Bayer, 1998; 
Esuoso et al., 2000) of the plant, while little or no attempt 
has been made to evaluate the safety of medicinal 
application of the extract of the fruit of L. breviflora. 
Recently, there has been increased or renewed aware-
ness in the populace of the benefit of medicinal plant in 
health care and more people are increasingly employing 
the use of these plants without any standard dose 
regime, which naturally is predisposed to over-dosage 






In the folklore medicine, herbal preparations are admi-
nistered as paste, powder and concoctions made from 
crude extractions of medicinal plants (Tiwari and 
Agrawal, 2003; Ramoutsaki et al., 2002; Brusell, 2005). It 
is therefore logical to evaluate possible deleterious effect 
of L. breviflora in its crude state. 
This study seeks to evaluate some serum biochemical 
changes accompanying prolonged administration of 
ethanolic extract fruit of L. breviflora with a view to having 
a balanced understanding of effects of L. breviflora on 
both human and animal body systems using the Wistar 
rat as experimental animal model.  
 
 




Fresh fruits of L. breviflora were obtained from Botanical Garden of 
University of Ibadan, Nigeria and identified at the Department of 
Botany and Microbiology of the University. A voucher sample of the 
plant was also deposited in the department. 
 
 
Extraction of the fruit 
 
Fresh fruits were washed, weighed and cut into small pieces. These 
pieces were collected and tied up in small portions in sieves and 
placed in ethanol (96%) in plastic containers. The ethanolic solution 
was drained regularly and replaced with fresh ethanol every 3 days. 
Each batch of harvested solvent were stored in plastic containers 
and refrigerated at 4°C. 
 
 
Separation of the extract 
 
The extract obtained was clarified by filtration through celite on 
water pump and was then concentrated in vacuo using a rotation 
evaporator at low temperatures. The ethanol remaining in the 
extract was finally removed by placing small volumes in porcelain 
dishes in the oven set at low temperature of 4°C. The extract came 
as semi-solid greenish-brown paste. A stock solution was prepared 





Fifty adult male rats were used for this study. They were housed at 
the Animal Housing Unit of the Department of Veterinary Physiology, 
Biochemistry and Pharmacology, University of Ibadan. The rats 
were fed with pelletized rat ration (Guinea Feed, Nig. Ltd). Water 
was given ad libitum and the rats were allowed to stabilize for 2 
weeks before commencement of the experiment. Twenty five rats 
were used to determine the safe dose range of the extract in an 
acute toxicity study which showed that doses above 8,000 mg/kg 
body weight of the rats caused mortality. The remaining 25 rats 
were randomly but equally divided into five groups.  
 
 
Dosing and collection of blood samples 
 
The rats in group A were administered with 0.9% physiological 
saline. While the four treatment groups B, C, D and E were 
administered with ethanolic extract of 1000, 2000, 4000 and 8000 
mg/kg   body   weight   of   the   rats,   respectively.  The   rats  were  




administered, orally with their various designated dosages once 
daily for 14 days using rat cannula. Blood was collected from each 
rat in fluoride oxalate bottles for glucose evaluation and in non-
heparinized bottles for other serum biochemical analysis. 
 
 
Serum biochemical parameters evaluated 
 
Serum lipid profile including total cholesterol (TC), triglycerides 
(TG), high density lipoprotein (HDL-C) and low density lipoprotein 
(LDL-C) were determined according to the method of Meiathnin et 
al. (1978). Total protein was measured using Biuret reaction 
(Lanzarot et al., 2005), while glucose and albumin levels were 
measured by spectrophotometric estimation using the Sigma 
Diagnostic Kit (Sigma Diagnostics, UK). Globulin was obtained from 
the difference of total protein and albumin. Serum enzymes such as 
alanine aminotransferase (ALT), aspartate aminotransferase (AST) 
and alkaline phosphatase (ALP) were determined by method of 
Duncan et al. (1994) using enzyme kits prepared by Randox Lab-
oratories Ltd, UK. Serum urea and creatinine levels were deter-
mined using spectrophotometric methods described by Coles 
(1986). The total bilirubin and conjugated bilirubin concentrations 
were determined as described by Balistreri and Shaw (1987). The 
unconjugated bilirubin concentration was calculated as the differe-





Student t-test statistic was used to analyze the values obtained 
from these determinations. The differences in the values were con-






Total cholesterol (TC) 
 
The mean total cholesterol values were lower in all the test groups 
when compared with the control group, but significant (P < 0.05) 
reductions were observed for rats in groups B (125.6 ± 7.23 mg/dl) 
and C (141.0 ± 8.20 mg/dl) relative to that of the rats in the control 





The mean serum triglycerides values were reduced non-
significantly (P > 0.05) in rats in groups B (62.0 ± 3.35 mg/dl) and C 
(69.4 ± 6.16 mg/dl), while the values were higher (P > 0.05) in 
groups D (99.5 ± 14.17 mg/dl) and E (81.6 ± 8.87 mg/dl) when 
compared with the values obtained for the rats in the control group 
(70.0 ± 5.18 mg/dl) (Table 1). 
 
 
High density lipoprotein-cholesterol (HDL-C) 
 
The values of mean serum high-density lipoproteins were observed 
to have be reduced in all the test groups when compared to that of 
the control rats (43.8 ± 5.11 mg/dl). The difference of the means is 
only significant (P < 0.05) between the control group (43.8 ± 5.11 
mg/dl) and C (40.5 ± 5.04mg/dl) (Table 1). 
 
 
Low density lipoprotein-cholesterol (LDL-C) 
 
The serum level of low density lipoproteins were observed  to  have 
 








Control (n = 5) 
Group B 
1000 mg/kg (n = 5) 
Group C 
2000 mg/kg (n = 5) 
Group D 
4000 mg/kg (n = 5) 
Group E 
8000 mg/kg (n = 5) 
TC (mg/dl) 163.6 ± 7.58
a
 125.6 ± 7.23
ab
 141.0 ± 8.2
 b
 149.0 ± 10.82 144.8 ± 11.27 
TG (mg/dl) 70.0 ± 5.18 62.0 ± 3.35
a
 69.4 ± 6.16 99.5 ± 14.17
a
 81.6 ± 8.87 
HDL-C (mg/dl) 43.8 ± 5.11 49.4 ± 2.69 48.2 ± 1.53 40.5 ± 5.04 38.4 ± 2.96 
LDL-C (mg/dl) 88.8 ± 4.39 79.0 ± 5.37 79.6 ± 3.84 75.5 ± 3.57 90.8 ± 6.45 
Glucose (mg/dl) 92.0 ± 7.87
abcd
 102.0 ± 14.97
a
 104.49 ± 0.69
b
 122.4 ± 0.26
c












Control (n = 5) 
Group B 
1000 mg/kg (n = 5) 
Group C 
2000 mg/kg (n = 5) 
Group D 
4000 mg/kg (n = 5) 
Group E 
8000 mg/kg (n = 5) 
TP (g/dl) 5.06 ± 0.25
ab
 5.68 ± 0.18
c
 6.54 ± 0.31
a
 5.54 ± 0.90 6.78 ± 0.26
bc
 
ALB (g/dl) 3.38 ± 0.11 3.64 ± 0.13 3.44 ± 0.14 3.42 ± 0.52 3.48 ± 0.15 
Glob (g/dl) 1.68 ± 0.21
a
 2.04 ± 0.18
b
 3.10 ± 0.44 2.42 ± 0.50 3.30 ± 0.18
ab
 
TBil (mg/ml) 0.62 ± 8.7 x 10
-3
 0.56 ± 8.6 x 10
-3
 0.44 ± 6.8 X 10
-3
 0.53 ± 6.3 x 10
-3
 0.36 ± 8.1 x 10
-3
 
CRT (mg/dl) 0.14 ± 2.4 x 10
–3
 0.18 ± 2.0 x 10
-3
 0.20 ± 1.0 x 10
-3
 0.34 ± 2.4 x 10
-3
 0.38 ± 3.7 x 10
–3
 
BUN (mg/dl) 67.6 ± 13.04
abcd
 115.4 ± 7.66
aef
 145.4 ± 7.80
be
 137.4 ± 5.12
cf








reduced (P > 0.05) for the treatment groups: B (79.0 ± 5.37 mg/dl), 
C (79.6 ± 3.84 mg/dl) and D (75.5 ± 3.57 mg/dl) when compared 
with that of the rats in the control group (88.6 ± 4.39 mg/dl). It was 
however increased (P > 0.05) for group E (90.8 ± 6.48 mg/dl) 
(Table 1).  
 
 




The mean values recorded for the glucose levels increased dose-
dependently for all the treatment groups: B (102.0 ± 14.97 mg/dl), C 
(104.49 ± 0.69 mg/dl), D (122.4 ± 0.26mg/dl) and E (237.23 ± 7.05 
mg/dl) over the values obtained for the rats in the control group 
(92.0 ± 7.87 mg/dl). The difference of the means is significant 




Plasma proteins and non-protein metabolites 
 
Total protein (TP) levels 
 
The mean serum total protein value increased for all the treatment 
groups when compared with that of the rats in the control group 
(5.06 ± 0.25 g/dl). The increase was significant (P < 0.05) for the 




Albumin (Alb) and globulin (Glob) levels 
 
The serum level of albumin fractions increased non-significantly (P 
> 0.05) for group B (3.64 ± 0.13 g/dl), C (3.44 ± 0.14 g/dl) and E 
(3.48 ± 0.15 g\dl), while that of group D was reduced (P > 0.05) 
relative to value obtained for the control group (3.38 ± 0.11 g/dl). 
The mean value of the globulin fraction increased in rats in all the 
treatment groups and the difference of the means were significant 
(P < 0.05) between the control and group D (Table 2).  
 
 
Total bilirubin  
 
The serum total bilirubin values decreased non-significantly (P > 
0.05) for rats in all the treatment groups: B (0.56 ± 8.6 x 10
-3 
mg/dl), 
C (0.44 ± 6.8 x 10
-3 
mg/dl), D (0.53 ± 6.3 x 10
-3 
mg/dl) and E (0.36 ±  
x 10
-3 
mg/dl) when compared with those of the rats in the control 
group (0.62 ± 8.7 x 10
-3 
mg/dl) (Table 2).  
 
 
Creatinine (CRT) level 
 
The serum creatinine levels of the rats increased non-significantly 
and dose-dependently in all the treatment groups: B (0.18 ± 2.0 x 
10
-3 
mg/dl), C (0.20 ± 1.0 x 10
-3 
mg/dl), D (0.34 ± 2.4 x 10
-3 
mg/dl) 
and E (0.38 ± 3.7 x 10
-3 
mg/dl) when compared with the values 






Blood urea nitrogen (BUN) level 
 
The mean blood urea nitrogen (BUN) values significantly (P < 0.05) 
increased in rats from group B (115.4 ± 7.66 mg/dl), C (145.4 ± 7.08 
mg/dl), D (137.4 ± 5.2 mg/dl) and E (108.4 ± 14.06 mg/dl) when 





Aspartate aminotransferase (AST) level 
 
There was no significant change in serum AST levels in  the  rats  in 
 








Control (n = 5) 
Group B 
1000 mg/kg (n = 5) 
Group C 
2000 mg/kg (n = 5) 
Group D 
4000 mg/kg (n = 5) 
Group E 
8000 mg/kg (n = 5) 
AST (U/L) 30.8 ± 1.88 30.8 ± 3.17 27.6 ± 1.57
a
 32.0 ± 1.68a 31.2 ± 2.92 
ALT (U/L) 26.6 ± 1.50 26.4 ± 2.58 22.2 ± 1.46 24.3 ± 1.93 26.0 ± 3.27 
ALP(U/L) 90.6 ± 3.31 74.2 ± 6.48
a
 82.0 ± 2.63
b












Alanine aminotransferase (ALT) level 
 
There was a marginal difference between the mean serum levels of 
ALT of the rats in each of the treatment groups: B (26.4 ± 2.58 U/L), 
C (22.2 ± 1.46 U/L), D (24.3 ± 1.93 U/L) and E (26.0 ± 3.27 U/L), 




Alkaline phosphatase (ALP) level 
 
The mean value of serum level of ALP obtained for rats in the 
control group (90.6 ± 3.31 mg/dl) was non-significantly higher than 
those of group B (74.2 ± 6.48 U/L) and C (82.0 ± 2.63 U/L) but 
lower than that of group D (101.3 ± 5.81 U/L) and E (108.2 ± 6.18 





No visible lesion was observed in the liver, kidney, heart and 
intestine of rats in group A. There was marked epithelial necrosis 
with goblet cell hyperplasia in the intestines of rats in groups B, C, 
D and E. Marked renal tubular degeneration and necrosis were 
observed in the rats in groups C and E with no visible lesions in 





In this study, there was a biphasic response by the serum 
lipid profile to the administration of ethanolic extract of 
whole fruit of L. breviflora. It was discovered that the 
lower doses of the extract (1000 and 2000 mg/kg body 
weight) lowered the serum levels of TC, TG and LDL-C, 
while HDL-C was elevated. Higher doses of 4000 and 
8000 mg/kg body weight of the extract increased the 
serum levels of TG and LDL-C, and lowers HDL-C level 
in the serum. The serum values of TC for doses of 4000 
and 8000 mg/kg body weight of extract though lower than 
that of the control, were nevertheless found to be 
comparatively higher than the serum level of TC recorded 
for the lower doses of the extract.  
It is inferable from the foregoing that the extract of the 
fruit of L. breviflora exhibits lipolytic effect at lower doses 
or put in another way; it does not have dyslipidaemic 
potential at lower doses, which is actually a desirable 
quality for a plant like L. breviflora that is extensively used 
as antiviral and antibacterial remedies in both man and 
animal (Burkill, 1985; Tomori et al., 2007). With this 
finding, the plant therefore compares favourably with 
many other medicinal plants like extracts of Calotropis 
procera (Akinloye et al., 2001), Allium cepa Linn (Kumari 
and Augusti, 2007), Indigofera tinctoria (Puri et al., 2007) 
and Gui Qui mixture (Zhang et al., 2006) that have been 
reported to exhibit some degree of lipolytic effect. This 
lipolytic effect of the whole fruit of L. breviflora would 
have added to many other existing claims of therapeutic 
effects of L. breviflora except for the fact that the lipid 
lowering effect was reversed at higher doses of the 
extract. At higher doses, the extract exhibited a high 
lipogenic effect which is believed to have arisen from the 
high triacylglycerol and fatty acid constituents of the fruit 
(Oshodi, 1996; Esuoso and Bayer, 1998). It should 
therefore be mentioned at this point, that administration 
of the extract of the plant as natural remedy should not 
be done wantonly because of its tendency to precipitate 
hyperlipidaemia and increase atherogenic indices 
characterized by elevation of serum TG and LDL-C, glu-
cose and lowered HDL-C levels.  
Dose-dependent hyperglycaemic effect was observed 
in rats administered with the extract. Hyperglycaemia has 
been consistently associated with subsequent develop-
ment of dyslipidaemia (Parikh et al., 2001; Emral et al., 
2005). There is need to find out how extract of L. 
breviflora elevates serum glucose level. Is the hypergly-
caemia related to the effect of the extract on insulin, 
glucocorticoids and other physiological processes or 
hormones associated with control of blood glucose level 
or was it for the fact that the extract is a rich source of 
metabolic sugar? One established fact is that the fruit has 
been reported to have a high amino acid content (Esuoso 
and Bayer, 1998) which may lead to increase gluconeo-
genesis through the intermediate metabolic pathways 
(Lehninger et al., 1993). The excess glucose formed can 
be converted to lipids additionally, thus leading to even-
tual rise in lipid profile as clearly observed in this study. 
Administration of extract of L. breviflora was also 
accompanied with elevated serum total protein level and 
the increase was observed for both the ALB and GLB 
fractions. Plasma proteins are predominantly synthesized 
by hepatocytes (Liang and Grieninger, 1981; Jefferson et 
al., 1983), which is the basis of the assumption that the 
increased level of serum proteins in this study is a direct 
effect of L. breviflora on  hepatic  functions,  especially on  
 




protein synthesis. Of more significance is the globulin 
fraction which strongly infers that the extract is also 
immuno-stimulant.  
It was observed that the serum total bilirubin was 
actually lowered in the test rats which are an indication 
that the extract did not exhibit hepatotoxicity. This was 
corroborated by histopathology report of no lesion or 
degeneration of hepatic tissue in this study. However, the 
serum CRT level increased dose-dependently and BUN 
was elevated two-fold in most of the test groups. These 
are strong indices of renal injury (Mazze et al., 2000; 
Waikar and Bonventre, 2006), which was confirmed by 
histopathological findings. Saba et al (2009) had earlier 
hinted on the nephrotoxic tendency of whole fruit of 
Lagenaria breviflora. The serum enzymes did not show 
any remarkable changes except for the serum ALP which 
was significantly increased in test rats admini-stered with 
the highest dose (8,000 mg/kg body weight) of the 
extract. The elevated serum ALP level may be an 
indication of hepatic injury (Jansen and Muller, 1999; 
Moseley, 1999) by the extract at the highest dose 
administered but this is not supported by the histopatho-
logical findings; however, injury of the gastrointestinal 
tract such as necrosis of the intestinal epithelium with 
goblet cell hyperplasia observed in this study is also 
known to be accompanied by elevated serum ALP 
(Wiwanitkit, 2001). 
In conclusion, it appears that therapeutic application of 
the extract of the whole fruit of L. breviflora is quite safe 
at doses below 2,000 mg/kg body weight in rats. There is 
a need to ascertain if the extract is potent at these doses 
for its ethno-medicinal applications. It is not advisable to 
take the extract at higher doses for long period because 
of its hyperglycaemic and dyslipidaemic effects which can 
easily predispose to diabetes mellitus, atherosclerosis 
and cardiopathy among other sequela. It is recommend-
ed that further studies be carried out to firmly establish 
metabolic basis of the hyperglycaemic and dyslipidaemic 
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